logo

CORZ

Core Scientific·NASDAQ
--
--(--)
--
--(--)
5.10 / 10
Netural

Core Scientific's fundamentals score moderately (5.1/10). Strengths include solid inventory turnover (232.5 days) and a favorable PB-ROE profile, while risks involve a high asset-liability ratio (149.1%) and elevated long-term debt to working capital (7.0%). Overall, the balance of factors suggests cautious optimism for investors willing to monitor downside risks closely.

Fundamental(5.1)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-1.98
Score2/3
Weight14.39%
1M Return7.62%
Asset-liability ratio (%)
Value149.13
Score2/3
Weight3.70%
1M Return1.95%
Profit-MV
Value0.47
Score3/3
Weight23.60%
1M Return10.76%
Net income-Revenue
Value-0.15
Score2/3
Weight4.48%
1M Return2.40%
PB-ROE
Value1.26
Score3/3
Weight19.98%
1M Return10.90%
Long-term debt to working capital ratio (%)
Value7.04
Score0/3
Weight0.26%
1M Return0.13%
Annualized return on total assets (%)
Value-34.68
Score3/3
Weight7.19%
1M Return3.17%
Asset-MV
Value-0.51
Score1/3
Weight11.71%
1M Return6.13%
Inventory turnover days
Value232.54
Score3/3
Weight2.70%
1M Return1.38%
Cash-MV
Value-0.00
Score2/3
Weight11.99%
1M Return7.14%
Is CORZ fundamentally strong?
  • CORZ scores 5.10/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, -229.91% net margin, -6.78 P/E ratio, -4.62 P/B ratio, and 48.94% earnings growth, these metrics solidify its Netural investment rating.